HLA-DRB1 and myeloid sarcoma: HLA genotype-clinical phenotype correlations have been reported, focusing on the major susceptibility alleles in Caucasian (HLA-DRB1*15:01) and Japanese MS patients (HLA-DRB1*15:01 and DRB1*04:05).